Neonatal alloimmune thrombocytopenia is not what it was a lesson learned from a large prospective screening and intervention program

Scandinavian Journal of Immunology

Volumn 70, Issue 6, 2009, Pages 531-534

  Skogen, B ^a,b   Husebekk, A ^a,b   Killie, M K ^a   Kjeldsen Kragh, J ^c,d  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COMPREHENSION; DISEASE SEVERITY; HUMAN; IMMUNIZATION; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; PATHOLOGY; PREDICTOR VARIABLE; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SCREENING;

EID: 70449956383     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02339.x     Document Type: Review

References (24)

1. Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989 83 : 1778 1781.
2. Kjeldsen-Kragh J, Killie MK, Tomter G et al. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007 110 : 833 839.
3. Kaplan C, Daffos F, Forestier F, Morel MC, Chesnel N, Tchernia G. Current trends in neonatal alloimmune thrombocytopenia: diagnosis and theraphy. In : Kaplan-Gouet C, Schlegel N, Salmon Ch, McGregor J, eds. Platelet Immunology: Fundamental and Clinical Aspects. Paris : Colloque INSERM/John Libbey Eurotext Ltd, 1991 : 267 278.
4. Mueller-Eckhardt C, Kiefel V, Grubert A et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989 1 : 363 366. (Pubitemid 19103082)
5. Muller JY, Reznikoff-Etievant MF, Patereau C, Dangu C, Chesnel N. Neonatal alloimmune thrombopenia. Clinical and biological study of 84 cases. Presse Med 1985 14 : 83 6.
6. Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001 41 : 45 55.
7. Ahlen MT, Husebekk A, Killie MK, Skogen B, Stuge TB. T cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4 + T cells. Blood 2009 113 : 3838 3844.
8. L'Abbe D, Tremblay L, Filion M et al. Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201. Hum Immunol 1992 34 : 107 114.
9. Williamson LM, Hackett G, Rennie J et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998 92 : 2280 2287.
10. Ahlen MT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Olsson LM, Skogen B. The development of severe anti-HPA 1a-related neonatal alloimmune thrombocytopenia is influenced by the maternal ABO type. Blood 2007 110 : 623a.
11. Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica 2008 93 : 870 877.
12. Tiller H, Killie MK, Skogen B, Oian P, Husebekk A. Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme. BJOG 2009 116 : 594 598.
13. Bussel JB, Zacharoulis S, Kramer K, McFarland JG, Pauliny J, Kaplan C. Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia. Pediatr Blood Cancer 2005 45 : 176 183.
14. Bussel JB, Primiani A. Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates. Blood Rev 2008 22 : 33 52.
15. Gruel Y, Boizard B, Daffos F, Forestier F, Caen J, Wautier JL. Determination of platelet antigens and glycoproteins in the human fetus. Blood 1986 68 : 488 492.
16. Giovangrandi Y, Daffos F, Kaplan C, Forestier F, Mac AJ, Moirot M. Very early intracranial haemorrhage in alloimmune fetal thrombocytopenia. Lancet 1990 336 : 310.
17. Murphy MF, Metcalfe P, Waters AH, Ord J, Hambley H, Nicolaides K. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions. Blood 1993 81 : 2174 2179.
18. Maslanka K, Guz K, Zupanska B. Antenatal screening of unselected pregnant women for HPA-1a antigen, antibody and alloimmune thrombocytopenia. Vox Sang 2003 85 : 326 327.
19. Turner ML, Bessos H, Fagge T et al. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005 45 : 1945 1956.
20. Uhrynowska M, Niznikowska-Marks M, Zupanska B. Neonatal and maternal thrombocytopenia: incidence and immune background. Eur J Haematol 2000 64 : 42 6.
21. Ghevaert C, Campbell K, Stafford P et al. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia. Transfusion 2007 47 : 1296 1305.
22. Bertrand G, Martageix C, Jallu V, Vitry F, Kaplan C. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. J Thromb Haemost 2006 4 : 628 637.
23. Jaegtvik S, Husebekk A, Aune B, Oian P, Dahl LB, Skogen B. Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn. BJOG 2000 107 : 691 694.
24. Killie MK, Husebekk A, Kaplan C, Taaning E, Skogen B. Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study. Transfusion 2007 47 : 55 58.